2008 annual financial data
BioCryst Pharmaceuticals 2008 Operating margin
BioCryst Pharmaceuticals 2008 operating margin with verified reported values.
Direct answer
Operating margin was -48.03%.
Operating income was -27,164,492 USD and net income was -24,731,570 USD.
Operating cash flow was -20,873,820 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 56,561,369 USD
- Operating income
- -27,164,492 USD
- Net income
- -24,731,570 USD
- Operating cash flow
- -20,873,820 USD